Inmed Pharmaceuticals In (IN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 176 | 29 | 29 | 27 | 37 |
| Accounts receivable | 1 | -3 | 58 | 85 | -97 |
| Other Working Capital | 481 | 168 | 1,011 | -1,746 | 176 |
| Other Operating Activity | -4,191 | -2,848 | -3,104 | -2,977 | -1,917 |
| Operating Cash Flow | $-3,534 | $-2,654 | $-2,006 | $-4,612 | $-1,801 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 306 | -250 | -2 | 0 | 0 |
| Investing Cash Flow | $306 | $-250 | $-2 | $0 | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 12,000 | 0 | 4,463 | N/A |
| Other Financing Activity | -836 | -1,115 | -83 | -418 | 6,958 |
| Financing Cash Flow | $-836 | $10,885 | $-83 | $4,045 | $6,958 |
| Exchange Rate Effect | 0 | 0 | 0 | 0 | 367 |
| Beginning Cash Position | 15,344 | 7,363 | 9,454 | 10,021 | 4,497 |
| End Cash Position | 11,280 | 15,344 | 7,363 | 9,454 | 10,021 |
| Net Cash Flow | $-4,064 | $7,981 | $-2,091 | $-567 | $5,156 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,534 | -2,654 | -2,006 | -4,612 | -1,801 |
| Free Cash Flow | -3,534 | -2,654 | -2,006 | -4,612 | -1,801 |